Health Care·Health Care Equipment·$158.4B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.30 | N/A | +0.15% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $1.30 | N/A | +0.15% |
| Revenue | N/A | N/A | N/A |
Tone: Cautiously Optimistic
Overall, management acknowledged the current market pressures while emphasizing their commitment to improving operational performance.
Management highlighted ongoing challenges in the market but expressed confidence in long-term growth.
They noted that operational efficiencies are being prioritized to enhance profitability.
Abbott Labs reported a slight earnings beat, but the stock fell by nearly 3% following the announcement. Investors may be reacting to the lack of revenue details and the absence of guidance, which could indicate uncertainty about future performance. The cautious tone from management may also have contributed to the stock's decline.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
GOLDMAN SACHS GROUP
Oct 14, 2025